Regulatory in brief | switches, paracetamol, ulipristal

11 September 2020 - Deborah Wilkes

Archived

A parliamentary group in the UK wants the progestogen-only pill to be made available without a prescription, research claims a link between paracetamol and risk taking, and Europe recommends withdrawing the marketing authorisation for a prescription version of ulipristal acetate.

Click tags below for more information on topics:

EMA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: